T. Rowe Price Associates’s Standard BioTools LAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $205K | Sell |
|
|||||
|
2025
Q2 | $252K | Buy |
|
|||||
|
2025
Q1 | $212K | Buy |
|
|||||
|
2024
Q4 | $318K | Buy |
|
|||||
|
2024
Q3 | $319K | Sell |
|
|||||
|
2024
Q2 | $293K | Buy |
|
|||||
|
2024
Q1 | $187K | Buy |
|
|||||
|
2023
Q4 | $60K | Sell |
|
|||||
|
2023
Q3 | $112K | Hold |
|
|||||
|
2023
Q2 | $75K | Sell |
|
|||||
|
2023
Q1 | $99K | Sell |
|
|||||
|
2022
Q4 | $99K | Buy |
|
|||||
|
2022
Q3 | $68K | Buy |
|
|||||
|
2022
Q2 | $28K | Sell |
|
|||||
|
2022
Q1 | $89K | Buy |
|
|||||
|
2021
Q4 | $89K | Sell |
|
|||||
|
2021
Q3 | $336K | Sell |
|
|||||
|
2021
Q2 | $362K | Buy |
|
|||||
|
2021
Q1 | $257K | Sell |
|
|||||
|
2020
Q4 | $460K | Buy |
|
|||||
|
2020
Q3 | $245K | Buy |
|
|||||
|
2017
Q4 | – | Sell |
|
|||||
|
2017
Q3 | $75K | Hold |
|
|||||
|
2017
Q2 | $60K | Hold |
|
|||||
|
2017
Q1 | $85K | Hold |
|
|||||
|
2016
Q4 | $108K | Hold |
|
|||||
|
2016
Q3 | $119K | Sell |
|
|||||
|
2016
Q2 | $208K | Hold |
|
|||||
|
2016
Q1 | $186K | Hold |
|
|||||
|
2015
Q4 | $249K | Buy |
|